Prof. Esra KAYTAN SAGLAM
Snapshot Highlights
- Head of Radiation Oncology Department at Memorial Şişli Hospital
- Former Medical Director of Istanbul University Oncology Institute
- Professor of Radiation Oncology at Istanbul University
- Extensive international publications and conference presentations
- Key leadership roles in prominent Turkish oncology societies
Radiation Oncology Expertise and Leadership
Prof. Esra KAYTAN SAGLAM is a distinguished leader in Radiation Oncology, bringing over two decades of dedicated experience to advanced cancer care. She currently heads the Radiation Oncology Department at Memorial Şişli Hospital, a position she has held since 2015, guiding the implementation of cutting-edge radiation treatment protocols. Her career is marked by significant leadership roles, including her tenure as Medical Director of the Oncology Institute at Istanbul University from 2013 to 2015. Prof. Saglam also previously led the Radiation Oncology Department at Bezmiâlem Vakıf University from 2012 to 2013, demonstrating broad influence in shaping oncology services.
Academic and Professional Journey
Prof. Saglam’s academic foundation was established at Istanbul University Istanbul Faculty of Medicine, where she completed her medical degree from 1986 to 1992. She then specialized in Radiation Oncology at the same esteemed institution from 1992 to 1996. Her academic career advanced significantly at Istanbul University, Istanbul Faculty of Medicine, where she served as an Associate Professor from 2004 to 2009, followed by a professorship in Radiation Oncology from 2009 to 2011. Her early years, from 1992 to 2004, were spent as a Specialist and Research Assistant in Radiation Oncology at Istanbul University, laying the groundwork for her extensive contributions to the field.
Contributions to Oncology Science
A prolific contributor to the field of oncology, Prof. Saglam has authored and co-authored numerous scientific works. Her research output includes 40 articles published in international peer-reviewed journals and 18 in national journals, highlighting her commitment to advancing global oncological knowledge. Furthermore, she has presented her findings at 24 international conferences and 150 national events, actively disseminating expertise within the medical community. Her scholarly work also extends to national books and book chapters, enriching educational resources for fellow medical professionals and solidifying her expertise in radiation oncology and comprehensive cancer management.
Professional Affiliations and Influence
Prof. Esra KAYTAN SAGLAM is a recognized authority and leader within the Turkish oncology landscape. She actively participates in and holds leadership positions within prestigious medical societies. Her impactful roles include serving on the Board of Directors and as Vice President for the Turkish Society of Radiation Oncology, and as a Board Member for the Turkish Lung Cancer Society. Additionally, she contributes as a Scientific Advisory Board Member for the Turkish Society of Oncology and is the Editor-in-Chief for their publications. Her involvement as a Scientific Advisory Board Member for Turkiye Klinikleri Journal of Medical Sciences and her membership in the European Society of Therapeutic Radiology and Oncology (ESTRO) underscore her significant standing and influence in both national and international oncology circles.
Commitment to Continuous Learning
Prof. Saglam maintains a strong dedication to ongoing professional development, ensuring her practice remains at the forefront of oncological advancements. She has consistently engaged in specialized vocational trainings, advanced courses, and numerous national and international congresses throughout her career. Notable participations include the TROD Chemotherapy Approaches Course and the TTOD Hematologic Malignancies Course. Her extensive engagement with events like multiple National Cancer Congresses, National Lung Cancer Congresses, and National Radiation Oncology Congresses, along with specialized symposia on lung cancer, melanoma, hereditary cancers, and evidence-based oncology, exemplifies her commitment to staying abreast of the latest medical innovations in cancer treatment and management.